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ABSTRACT
Objective To examine the association between smoking
and risk of invasive breast cancer using quantitative
measures of lifetime passive and active smoking
exposure among postmenopausal women.
Design Prospective cohort study.
Setting 40 clinical centres in the United States.
Participants 79990 women aged 50–79 enrolled in the
Women’s Health Initiative Observational Study during
1993–8.
MainoutcomemeasuresSelfreportedactiveandpassive
smoking, pathologically confirmed invasive breast
cancer.
Results In total, 3520 incident cases of invasive breast
cancer were identified during an average of 10.3 years of
follow-up.Comparedwithwomenwhohadneversmoked,
breast cancer risk was elevated by 9% among former
smokers (hazard ratio 1.09 (95% CI 1.02 to 1.17)) and by
16% among current smokers (hazard ratio 1.16 (1.00 to
1.34)). Significantly higher breast cancer risk was
observed in active smokers with high intensity and
duration of smoking, as well as with initiation of smoking
in the teenage years. The highest breast cancer risk was
found among women who had smoked for ≥50 years or
more (hazard ratio 1.35 (1.03 to1.77) compared with all
lifetime non-smokers, hazard ratio 1.45 (1.06 to 1.98)
compared with lifetime non-smokers with no exposure to
passive smoking). An increased risk of breast cancer
persisted for up to 20 years after smoking cessation.
Among women who had never smoked, after adjustment
for potential confounders, those with the most extensive
exposure to passive smoking (≥10 years’ exposure in
childhood, ≥20 years’ exposure as an adult at home, and
≥10 years’ exposure as an adult at work) had a 32%
excessriskofbreastcancercomparedwiththosewhohad
never been exposed to passive smoking (hazard ratio
1.32 (1.04 to 1.67)). However, there was no significant
association in the other groups with lower exposure and
no clear dose response to cumulative passive smoking
exposure.
Conclusions Active smoking was associated with an
increase in breast cancer risk among postmenopausal
women. There was also a suggestion of an association
between passive smoking and increased risk of breast
cancer.
INTRODUCTION
Experimental studies have shown that compounds
found in tobacco smoke, such as polycyclic hydro-
carbons, aromatic amines, and N-nitrosamines, may
induce mammary tumours.
1 The detection of smok-
ing-specific DNA adducts and mutations in the
p53 gene in the breast tissue of smokers supports the
biologicalplausibilityofapositiveassociationbetween
cigarette smoking and breast cancer.
2-6 Despite this
mechanisticevidence,systematicreviewsofepidemio-
logical studies published as of 2002 concluded that
there was no overall association between active smok-
ing and breast cancer risk, and attributed conflicting
results of individual studies in part to the confounding
effects of alcohol.
17-10 However, recent reappraisals of
evidence
1112 from recent cohort studies
13-19 have sug-
gested an increased risk of breast cancer that is inde-
pendent of the effects of alcohol among women who
smoked cigarettes for a long period of time or who
started smoking at a young age.
Similarly, studies of passive smoking suggest an
increased risk of breast cancer, particularly case-con-
trol studies that have conducted a more thorough
assessmentofexposure.
20-24Thesereportsfoundstron-
ger evidence of an association of passive smoking and
breast cancer in younger, primarily premenopausal
women, whereas the evidence in older or postmeno-
pausal women was inconclusive. Although cohort stu-
dies are generally considered less subject to bias than
case-control studies, assessment of passive smoking
has generally been less comprehensive in large cohort
studies than in case-control studies.
161825-29 Despite
limited evaluations of exposure, which may lead to
exposure misclassification and bias the relative risk
towards the null, several of these studies found
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subgroupsofwomenwhoreportedbeingmoreheavily
exposed.
27-29 Only one published cohort study
includesfullinformationonthreemajoraspectsoflife-
time exposure to passive smoking (childhood, adult
residential, and adult occupational), and this study
foundincreasedbreastcancerriskinaheavilyexposed
subgroup.
30 Thus, prospective studies with more
detailed assessment of passive smoking are needed to
elucidatetheassociationofpassivesmokingandbreast
cancer risk, especially in postmenopausal women.
In the Women’s Health Initiative Observational
Study, detailed information regarding active and pas-
sive smoking exposure was collected, including ques-
tions on passive exposure to cigarette smoke in
childhood and adult exposure both in the home and at
work. In the present study, we used data from the
Women’s Health Initiative that included a large num-
ber of breast cancer cases and detailed exposure infor-
mation to address the relation between active and
passivesmokingandtheriskofbreastcancerinpostme-
nopausal women. Further, given that breast cancer is a
heterogeneous disease with subtypes that may vary in
their aetiologies, we explored whether the effects of
activeorpassivesmokingdifferedbydiseasesubgroups
defined by hormone receptor status or histology.
METHODS
Women’s Health Initiative
The Women’s Health Initiative Observational Study
was designed to address major causes of morbidity
and mortality in postmenopausal women.
31 A total of
93676womenaged50–79wererecruitedat40clinical
centres throughout the United States from 1993 to
1998.
3233 Women were excluded if they did not plan
to reside in the area for at least three years, if they had
conditions predictive of survival less than three years,
or had complicating conditions such as alcoholism,
drug dependency, or dementia. The study was over-
seen by ethics committees at all 40 clinical centres
and at the coordinating centre, as well as by a data
and safety monitoring board. All participants in the
study gave informed consent and were followed pro-
spectively. Of the original cohort of 93676, we
excluded 12075 with a history of cancer (except non-
melanoma skin cancer) at baseline, 443 who had no
follow-up time, and 1168 with missing valuesof smok-
ing status. This yielded a sample of 79990 women for
further analysis.
Measurement of exposures and confounders
Allinformationonexposuresandconfoundersusedin
this analysis was collected at baseline. Information on
active smoking included smoking status (never, for-
mer, or current), and women who were current or for-
mer smokers were also asked the age at which they
started smoking, the number of cigarettes smoked per
day, and the durationof smoking in years. Amongfor-
mer smokers, age at quitting smoking was also col-
lected. Pack years of smoking were calculated by
multiplying the total years of smoking by the number
of cigarettes smoked a day divided by 20.
Questionsonexposuretopassivesmokingrelatedto
each of the following: childhood (<18 years old), adult
home, adult work, current home, and current work
(yes or no). Women who reported any of these expo-
sures were also asked the number of years of exposure
in childhood, as an adult at home, and as an adult at
work (predefined categories <1, 1–4, 5–9, 10–18 for
childhood exposure; <1, 1–4, 5–9, 10–19, 20–29, 30–
39, ≥40 for adult exposure at home or work).
The potential confounders used in multivariable
analyses included age at enrolment (<55, 55–59, 60–
64, 65–69, 70–74, ≥75 years), ethnicity (American
Indian or Alaska native, Asian or Pacific Islander,
black or African-American, Hispanic or Latino, non-
Hispanic white, and other), education (high school or
less,somecollegeortechnicaltraining,collegeorsome
post-college, and master’s degree or higher), body
mass index (<18.5, 18.5–24.9, 25.0–29.9, 30.0–34.9,
35.0–39.9, ≥40), physical activity (metabolic equiva-
lent tasks per week <5, 5–<10, 10–<20, 20–<30, ≥30),
alcoholintake(non-drinker,formerdrinker,<1drink/
month, 1 drink/month–<1 drink/week, 1–<7 drinks/
week, ≥7 drinks/week), parity (never pregnant, never
had term pregnancy, 1, 2, 3, 4, ≥5), family history of
breastcancer(yes/no),historyofhormonetherapyuse
(none, oestrogen alone, oestrogen and progestin,
mixed), age at menarche (≤12, 12–13, 14–15,
≥16 years), and age of first live birth (never had term
pregnancy, <20, 20–29, ≥30 years).
Follow-up and ascertainment of cases
Initialreportsofcancerwereascertainedbyannualself
administered questionnaires, and all reports of breast
cancer were confirmed by review of medical records,
including pathology reports (if a biopsy or resection
was done). The breast cancer cases were then coded
byanexperiencedcoderinaccordancewiththecoding
guidelines from Surveillance Epidemiology and End
Results.
34 Primary tumour site and histology were
coded in accordance with the ICD-O-2 (international
classificationof diseasesforoncology,secondedition).
The completion rate of annual questionnaires was
93%–96%.
In this study, we included only invasive breast can-
cercases;casesofcarcinomain situwerenot included.
By 14 August 2009, with an average 10.3 years of fol-
low-up, 3520 incident cases of invasive breast cancer
had been identified. Among 41022 women who had
never smoked, 1692 cases were identified, and these
cases were used for the passive smoking analysis.
Statistical analysis
Analysis of the association of passive smoking with
breast cancer risk was limited to the 41022 women
who had never smoked. Before analysing the data, we
developed a method to combine data on all passive
smoking exposures, including exposure during child-
hood, adult home exposure, and work exposure. We
constructed a new variable using the mutually
RESEARCH
page 2 of 8 BMJ | ONLINE FIRST | bmj.comexclusivecategoriesofnoexposure,exposureinchild-
hood only, adult exposure at home only, adult expo-
sure at work only, exposure to any two combinations,
and exposure to all three. Based on the distribution of
responses, we dichotomised childhood exposure as
<10 or ≥10 years, adult exposure at home as <20 or
≥20 years, and adult exposure at work as <10 or
≥10years.Withinthetripleexposurecategory,wecre-
ated an additional “extensive exposure” group,
defined as exposure in childhood ≥10 years, adult
home exposure ≥20 years, and adult work exposure
≥10 years. Of the 41022 never smokers, 2956 (7.2%)
had “extensive exposure” to passive smoking.
In addition to the above variables defined a priori,
we derived some categories after initial analysis in
order to estimate the cumulative dose of exposure to
passive smoking. We assigned mean values for each
exposure category in the original questionnaire
response and simply summed up all three types of
exposure years. We assessed exposure for ≥10 years
in childhood plus summed mean years of adult expo-
sure,weightingadulthomeexposurethreetimesmore
heavily, based on the estimate of time spent at home
comparedwithatwork.
35Wealsoappliedvariousmul-
tipliers to workplace exposure ranging from 0.8 to 1.5
based on the work of Hammond et al.
3536 Finally, we
examined additional categories of dual and triple
exposurebasedonouroriginaldichotomousvariables,
including the “extensive exposure” group defined a
priori.
We estimated hazard ratios for active smoking com-
pared with two reference groups. In the primary ana-
lysis, the referencegroup was lifetime non-smokers;in
a secondary analysis we used the much smaller refer-
ence group of lifetime non-smokers with no history of
passive smoking.
Cox proportional hazards regression models were
used to estimate hazard ratios and 95% confidence
intervals, adjusting for the potential confounders
describedaboveinmeasurementofexposureandcon-
founders. Participants without complete data for all
covariates in a given multivariable model were
excluded from that analysis. Follow-up time for each
woman was accrued from enrolment to the date of
diagnosis of invasive breast cancer, death, loss to
follow-up (including non-participation in an extension
of the study starting in 2005), or the administrative
censoring date (14 August 2009), whichever occurred
first. Tests for trend were performed by using the
ordered category, including the reference, as a contin-
uous variable in the proportional hazard model. The
proportionality assumption was satisfied for all expo-
sure variables of interest and potential confounding
variables based on graphs of scaled Schoenfeld
residuals.
37 All statistical analyses were conducted
using SAS (Version 9.0, SAS Institute, Cary, NC).
RESULTS
Table 1 shows the baseline characteristics of the study
subjects by disease status. Women who developed
invasive breast cancer were slightly older than
women who did not, but their body mass index and
physical activity were similar. Compared with
women who remained free of breast cancer, those
who developed the disease were significantly more
likelytobenon-Hispanicwhite,morehighlyeducated,
nulliparous, older at first live birth, and to have a his-
tory of taking oestrogen plus progesterone hormone
therapy, heavier alcohol intake, and a family history
of breast cancer (all P values <0.05). Women who
developed breast cancer were also less likely to have
never smoked that those who did not develop cancer
(48.1% v 51.4%). Among lifetime non-smokers, 88.1%
were exposed to passive smoking, and most women
had multiple types of passive smoking exposure.
Childhood exposure only was slightly higher among
the non-smokers who developed breast cancer than
those who did not, as was multiple types of passive
smoking exposure (table 1).
Among women who had never smoked, we did not
observeasignificantassociationbetweenbreastcancer
riskandpassivesmokingexceptforthehighestlevelof
exposure (childhood exposure ≥10 years, adult home
exposure ≥20 years, and adult work exposure
≥10 years) (table 2). We also did not observe a signifi-
cant dose-responsetrendfor any methodofestimating
Table 1 |Baseline characteristics of 79 990 postmenopausal women by diagnosis of invasive
breast cancer (values are numbers (percentages) of women unless stated otherwise)
Variable Cases Non-cases
P value of
difference*
Total No of women 3520 76 470
Mean (SD) age at baseline (years) 63.7 (7.1) 63.4 (7.3) 0.006
Mean (SD) body mass index (kg/m
2) 27.4 (5.7) 27.2 (5.8) 0.07
Mean (SD) physical activity (METs/week) 13.7 (13.6) 13.8 (14.4) 0.8
Non-Hispanic white ethnicity 3126 (88.8) 63 356 (82.9) <0.0001
Higher educational status† 1674 (47.6) 31 827 (41.6) <0.0001
Age at menarche <12 years 439 (12.5) 8792 (11.5) 0.2
Hormone therapy use:
Oestrogen alone 986 (28.0) 23 714 (31.0)
<0.0001 Oestrogen plus progestin 1082 (30.7) 17 842 (23.3)
Mixed use 262 (7.4) 4699 (6.1)
Nulliparous 496 (14.1) 9484 (12.4) <0.0001
Age at first live birth ≥30 years 337 (9.6) 5695 (7.5) <0.0001
Alcohol intake ≥7 drinks/week 552 (15.7) 9418 (12.4) <0.0001
Family history of breast cancer 812 (23.1) 13 379 (17.5) <0.0001
Smoking status:
Never smoked: 1692 (48.1) 39 330 (51.4)
<0.0001
Exposure to passive smoking:
None 145 (8.6) 3609 (9.2)
Childhood only 110 (6.5) 2241 (5.7)
Adult at home only 88 (5.2) 2436 (6.2)
Adult at work only 199 (11.8) 4800 (12.2)
More than one type 1118 (66.1) 25 132 (63.9)
Unknown 32 (1.9) 1112 (2.8)
Former smokers 1619 (46.0) 32 371 (42.3)
Current smokers 209 (5.9) 4769 (6.2)
SD=standard deviation. METs=metabolic equivalent tasks.
*χ
2 test between cases and non-cases. Significant for age, race, education, hormone therapy use, parity, age of
first live birth, alcohol intake, and family history of breast cancer (all P values <0.05).
†College graduate or above.
RESEARCH
BMJ | ONLINE FIRST | bmj.com page 3 of 8cumulative exposure, with all the estimates being qua-
litatively similar to the categorical results shown in
table 2. In the women who had never smoked with
the most extensive exposure to passive smoking, we
observed a 32% (95% confidence interval 4% to 67%)
excess risk of breast cancer (table 2).
Weassessedtheriskofbreastcancerassociatedwith
different measures of active smoking by including or
excluding passive smokers in the reference category
who had never smoked (table 3). In the primary ana-
lysis, with all lifetime non-smokers as the reference
group, breast cancer risk was elevated by 9% (2% to
17%) among former smokers and by 16% (0% to
34%, P=0.05) among current smokers. Compared
with never smoking, the risk of breast cancer was posi-
tively associated with smoking intensity, smoking
duration, and pack years of cigarette smoking, and
inversely associated with age at smoking initiation.
Compared with never smokers who had at least one
full term pregnancy, women who began smoking
before their first full term pregnancy had a 21% (11%
to 33%) elevated risk of breast cancer. All trend tests
were statistically significant. The highest breast cancer
risk was found among women who had smoked for
≥50 years (hazard ratio 1.35 (1.03 to 1.77)). Among
former smokers, the years since quitting smoking was
significantly inversely associated with breast cancer
risk. An increased risk of breast cancer persisted for
up to 20 years after smoking cessation.
Since extensive exposure to passive smoking was
associated with increased breast cancer risk, which
could result in underestimating the risks of active
smoking,weconductedasecondaryanalysisusinglife-
time non-smokers with no history of any exposure to
passive smoke as the reference group. In general, the
point estimates of active smoking risks in this second-
ary analysis were higher than those based on inclusion
ofpassivesmokersinthereferencegroupbutwereless
precise because of the much smaller size of the refer-
ence group. The hazard ratio for breast cancer among
current smokers was significantly elevated (P<0.05)
regardless of the reference group used, as was the risk
among women who started smoking before their first
term pregnancy, smoked for ≥50 years, or had ≥50
pack years of smoking (table 3).
Finally, we assessed the association between smok-
ing exposure and the risk of breast cancer for different
types of breast cancer (table 4). There was no signifi-
cantassociationofextensivepassivesmokingwithany
breast cancer type, but statistical power was limited by
the small sample sizes. There was a non-significant
trend towards a stronger association of current smok-
ing with lobular cancer than with ductal cancer (P for
interaction=0.13). Although there was a significant
association of former and current smoking with
tumours that were hormone receptor positive (for
both oestrogen and progesterone, the dominant sub-
type), statistical power was probably too limited to
assesswhetherthiswastruewithotherhormonerecep-
torsubtypes(Pforinteraction>0.2)(table 4).Whenwe
examined the associations of the different variables of
active smoking (including age of smoking initiation,
intensity, duration, and pack years of smoking) on the
risk of breast cancer for these subgroups, we found
similar patterns to that of breast cancer overall for
dominantsubtypes(ductalcancerandhormonerecep-
tor positive) and no clear pattern for other subtypes
(data not shown).
Table 2 |Cases of incident invasive breast cancer and related hazard ratios associated with exposure to passive smoking
among 41 022 postmenopausal women who had never smoked
Exposure to passive smoking No of cases
Hazard ratio (95% Cl)
Age adjusted Multivariable adjusted*
None 145 1.00 (reference) 1.00 (reference)
Any: 1515 1.08 (0.91 to 1.28) 1.09 (0.92 to 1.29)
Childhood only 110 1.22 (0.95 to 1.56) 1.19 (0.93 to 1.53)
Adult at home only 88 0.89 (0.69 to 1.16) 0.91 (0.70 to 1.19)
Adult at work only 199 1.02 (0.83 to 1.27) 1.01 (0.82 to 1.26)
Childhood + adult at home 170 1.02 (0.81 to 1.27) 1.04 (0.83 to 1.30)
Childhood + adult at work 191 1.18 (0.95 to 1.47) 1.17 (0.94 to 1.45)
Adult at home + at work 236 1.12 (0.91 to 1.38) 1.15 (0.93 to 1.41)
Childhood + adult at home + at work 521 1.09 (0.90 to 1.31) 1.11 (0.92 to 1.34)
Cumulative exposure categories:
No childhood + any adult 524 1.04 (0.86 to 1.24) 1.05 (0.87 to 1.26)
Childhood <10 years + any adult 154 1.10 (0.88 to 1.39) 1.13 (0.90 to 1.42)
Childhood ≥10 years + adult at home <20 years + adult at work <10 years 421 1.14 (0.95 to 1.38) 1.13 (0.94 to 1.37)
Childhood ≥10 years + adult at home <20 years + adult at work ≥10 years 151 0.99 (0.79 to 1.24) 0.98 (0.77 to 1.23)
Childhood ≥10 years + adult at home ≥20 years + adult at work <10 years 124 0.99 (0.78 to 1.25) 1.05 (0.82 to 1.33)
Childhood ≥10 years + adult at home ≥20 years + adult at work ≥10 years† 146 1.27 (1.01 to 1.60) 1.32 (1.04 to 1.67)
P value for trend§ 0.16 0.10
*Variables used in multivariable models included age at enrolment, ethnicity, education, body mass index, physical activity, alcohol intake, parity,
family history of breast cancer, hormone therapy use, age at menarche, and age of first live birth.
†The “extensive exposure” variable defined a priori.
§Including the reference group (no exposure) and the 6 rows of cumulative exposure categories.
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In this large prospective study in postmenopausal
women, we observed an elevated risk of breast cancer
in former smokers (9%) and current smokers (16%),
particularly with smoking of high intensity, of long
duration, and which started at an early age. Among
former smokers, the time since quitting smoking was
significantly inversely associated with breast cancer
risk, and it took up to 20 years for a former smoker’s
risk to return to baseline. Finally, we observed a 32%
excess risk of breast cancer associated with the most
extensive exposure to passive smoking among
women who had never been active smokers.
Comparison with other studies
Untilrecently,mostscientistsagreedthattherewasnot
enough consistent evidence to determine whether
active smoking plays a causal role in breast
cancer.
17-10 However, a Canadian panel of experts
reviewed the extensive new research in this area and
concluded that the relations between active smoking
andbreastcancer,bothpremenopausalandpostmeno-
pausal, are consistent with causality, based on the
weightofevidencefromepidemiologicalandtoxicolo-
gical studies and on an understanding of biological
mechanisms.
12 Our findings on active smoking are
consistent with the most recent studies reporting a
risk elevation of around 20%–50% in association with
high intensity smoking of long durationand with early
age at smoking initiation or smoking initiation before
their first pregnancy among postmenopausal
women.
13-1938-40
Our results also indicate that the elevated risk of
breast cancer that smokers experience declined over
time after smoking cessation, and it took up to
20 years for a former smoker’s risk to return to base-
line. Few studies have evaluated this relation in post-
menopausal women, and their results were
inconsistent. Some studies of predominantly postme-
nopausal women observed no relation between years
since quitting smoking and breast cancer risk,
151618
whereas other studies found results similar to
ours.
2038
Our study is one of few prospective studies to
observe a significantly increased risk of breast cancer
associatedwithpassivesmokingamongpostmenopau-
sal women. It seems unlikely that this could be
explained by bias or confounding for several reasons.
Firstly,our studyis a prospective study,whichcircum-
vents problems of recall and selection bias common to
case-control studies. In addition, the results remained
similar when we excluded the first two years of follow-
up (relative risk 1.38 (1.07 to 1.78) for the most exten-
sive passive exposure). Secondly, we were able to
adjust for all commonly known or suspected confoun-
dersforbreastcancer.Thirdly,ourstudycollecteddata
onthreemajoraspectsoflifetimeexposure(childhood,
adult residential, and occupational), which enabled us
toexamineareferencegroupthathadbeenunexposed
to either active or passive smoking. Although our
extensive variable of passive smoking exposure was
Table 3 |Cases of incident invasive breast cancer and related hazard ratios associated with
smoking status among 79 990 postmenopausal women
Smoking status
No of
cases
Hazard ratio (95% Cl)
Multivariable adjusted* Multivariable adjusted†
Never smoked: 1692 1.00 (reference) —
With no exposure to passive smoking 145 — 1.00 (reference)
With exposure to passive smoking 1515 — 1.08 (0.91 to 1.28)
Former smokers 1619 1.09 (1.02 to 1.17) 1.16 (0.98 to 1.38)
Current smokers 209 1.16 (1.00 to 1.34) 1.24 (1.00 to 1.54)
Age at starting smoking (years):
<15 112 1.12 (0.92 to 1.36) 1.19 (0.93 to 1.53)
15–19 940 1.13 (1.04 to 1.23) 1.21 (1.01 to 1.44)
20–24 581 1.09 (0.99 to 1.20) 1.16 (0.97 to 1.40)
25–29 110 1.02 (0.84 to 1.24) 1.09 (0.85 to 1.40)
≥30 80 0.94 (0.75 to 1.18) 1.00 (0.76 to 1.32)
P value for trend 0.002 0.04
Smoking started before first term
pregnancy‡:
Yes 833 1.21 (1.11 to 1.33) 1.28 (1.06 to 1.55)
No 116 1.12 (0.92 to 1.36) 1.17 (0.90 to 1.52)
Uncertain 618 1.07 (0.97 to 1.18) 1.13 (0.93 to 1.37)
Average No of cigarettes smoked/day:
<5 383 1.05 (0.94 to 1.17) 1.12 (0.92 to 1.35)
5–14 560 1.11 (1.01 to 1.23) 1.19 (0.99 to 1.43)
15–24 503 1.14 (1.03 to 1.27) 1.22 (1.01 to 1.47)
≥25 301 1.08 (0.95 to 1.22) 1.15 (0.94 to 1.41)
P value for trend 0.01 0.16
Total No of smoking years:
<5 220 0.97 (0.84 to 1.11) 1.03 (0.86 to 1.28)
5–9 182 1.05 (0.90 to 1.22) 1.12 (0.90 to 1.40)
10–19 401 1.09 (0.98 to 1.22) 1.17 (0.96 to 1.42)
20–29 387 1.09 (0.97 to 1.22) 1.16 (0.96 to 1.41)
30–39 341 1.21 (1.07 to 1.36) 1.29 (1.06 to 1.58)
40–49 178 1.14 (0.98 to 1.34) 1.22 (0.98 to 1.53)
≥50 56 1.35 (1.03 to 1.77) 1.45 (1.06 to 1.98)
P value for trend 0.0002 0.002
No of smoking pack years:
<10 702 1.04 (0.95 to 1.14) 1.11 (0.93 to 1.33)
10–<20 359 1.21 (1.08 to 1.36) 1.29 (1.06 to 1.58)
20–<30 225 1.13 (0.98 to 1.30) 1.21 (0.98 to 1.50)
30–<40 168 1.01 (0.86 to 1.19) 1.08 (0.86 to 1.36)
40–<50 69 1.16 (0.91 to 1.47) 1.24 (0.92 to 1.65)
≥50 218 1.18 (1.02 to 1.37) 1.26 (1.02 to 1.57)
P value for trend 0.005 0.08
Years since quitting smoking
(former smokers):
<10 295 1.15 (1.01 to 1.31) 1.19 (0.96 to 1.47)
10–<20 416 1.14 (1.02 to 1.27) 1.17 (0.96 to 1.43)
20–<30 391 1.08 (0.96 to 1.21) 1.11 (0.91 to 1.36)
≥30 414 1.06 (0.95 to 1.18) 1.08 (0.89 to 1.32)
P value for trend 0.005 0.08
*Reference category was lifetime non-smokers.
†Reference category was lifetime non-smokers with no history of exposure to passive smoking.
‡Among 69 533 women who had at least one full term pregnancy, 1429 cases were among never smokers and
125 cases in no exposure group.
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cumulative exposure, raising the possibility that the
result was due to chance.
Previous epidemiological studies examining the
association between passive smoking and breast can-
cerprovidedlittleevidencefora relationinpostmeno-
pausal women.
161825-294142 However, all but one of
these cohort studies had important limitations in
terms of exposure assessment. Given the high preva-
lence of passive smoking exposure in the population
(more than 80% of women in Western populations
have been exposed to regular residential or occupa-
tional passive smoking exposure),
20 inadequate assess-
ment of exposure to passive smoking could have
resultedinunderestimatingthe passivesmokingexpo-
sure status of most of those categorised as unexposed,
thus contaminating the reference group and leading to
an underestimate of risk. Johnson conducted a litera-
turereviewandfoundthatstudieswithmorecomplete
ascertainment of lifetime exposure, and which
excluded women with passive smoking exposure
from the reference group, consistently show higher
breast cancer risks in association with passive
smoking.
20-2443 Recently, one cohort study that
included a comprehensive measure of lifetime expo-
sure to passive smoking
30 also observed an increased
riskinthemosthighlyexposedsubgroupofpostmeno-
pausal women whose passive smoking began after
20 years of age (hazard ratio 1.25 (1.01 to 1.56)).
Possible biological mechanisms
The association of both active and passive smoking
withincreasedriskofbreastcancerisbiologicallyplau-
sible, especially when exposure occurs during certain
criticalperiods.Animalmodelshaveshownthatmam-
mary tissue may be particularly susceptibleto carcino-
genic exposures during the years from start of puberty
to first full term pregnancy.
1 Breast epithelial cells do
not become fully differentiated until after the first full
termpregnancy.Thus,theperiodbetweentheonsetof
puberty and first full term pregnancy may be a time of
higher risk of cancer initiation.
44 Our findings of an
elevated risk of breast cancer associated with early
age of starting smoking (<15 years old) and starting
smoking before first full term pregnancy support the
hypothesis that smoking during the early teenage
years increases the risk of breast cancer.
44 Alterna-
tively, these results may simply be correlated with a
long duration of smoking, which was also associated
with increased risk in our cohort.
In addition,human biomarkerstudieshave strongly
suggested that breast tissue is a target for the carcino-
genic effects of tobacco smoke.
2 Studies have found
thatDNAadducts(DNAcovalentlybondedtoacarci-
nogenic chemical) with derivatives of tobacco smoke
are more common in the breast tissue of smokers than
that of non-smokers.
64546The wide variation between
people in DNA adduct formation and repair is likely
relatedtoacombinationoffactors,includingtheprop-
erties of individual carcinogens and host genetic poly
morphisms.
47 In 1996 Ambrosone et al reported that
postmenopausalwomenwhosmokedandhadtheslow
acetylatorgenotypeforN-acetyltransferase2hadasig-
nificantly elevated risk of breast cancer.
48 A recent
meta-analysis of 13 studies of this association reached
the same conclusion.
49
Breast cancer is a heterogeneous disease with sub-
types that may vary in their aetiologies. Our data sug-
gestthatcurrentsmokingwasmorestronglyassociated
with lobular cancer than with ductal cancer and with
tumoursthatwerehormonereceptorpositive(forboth
oestrogenandprogesterone)thantheotherthreecom-
binations of receptor status. One study examining
smoking in relation to the risk of different histological
Table 4 |Cases of incident invasive breast cancer and related hazard ratios among 79 990 postmenopausal women by cancer subtypes and exposure to
tobacco smoke
Passive smoking exposure* Active smoking status
Never†
No of
cases
Any exposure
Non-extensive
exposure‡
Extensive
exposure‡
Never†
No of
cases
Former Current
No of
cases
Hazard
ratio
(95% CI)
No of
cases
Hazard
ratio
(95% CI)
No of
cases
Hazard
ratio
(95% CI)
No of
cases
Hazard
ratio
(95% CI)
No of
cases
Hazard
ratio (95%
CI)
Cases defined by histology
Ductal
cancer
98 969 1.02 (0.83
to 1.26)
878 0.99 (0.80
to 1.23)
91 1.20 (0.90
to 1.61)
1088 1013 1.07 (0.98
to 1.18)
91 1.16 (0.97
to 1.40)
Lobular
cancer
14 157 1.22 (0.70
to 2.11)
147 1.25 (0.72
to 2.17)
10 0.97 (0.43
to 2.22)
175 164 1.08 (0.86
to 1.35)
27 1.64 (1.09
to 2.49)
Cases defined by hormone receptor
OR+ PR+ 93 941 1.04 (0.84
to 1.29)
851 1.01 (0.82
to 1.26)
90 1.23 (0.91
to 1.65)
1052 1049 1.12 (1.03
to 1.22)
139 1.28 (1.07
to 1.53)
OR+ PR– 18 184 1.14 (0.70
to 1.86)
165 1.09 (0.67
to 1.78)
19 1.53 (0.79
to 2.94)
207 213 1.18 (0.97
to 1.44)
13 0.98 (0.63
to 1.53)
OR– PR– 20 160 1.10 (0.69
to 1.75)
193 1.08 (0.68
to 1.72)
21 1.39 (0.74
to 2.58)
237 194 1.00 (0.82
to 1.22)
21 0.98 (0.65
to 1.49)
OR+ = oestrogen receptor positive. OR– = oestrogen receptor negative. PR+ = progesterone receptor positive. PR– = progesterone receptor negative.
*Analyses performed only among lifetime non-smokers.
†Reference categories for hazard ratios. For active smoking, all non-smokers formed the reference category regardless of passive smoking exposure.
‡Extensive exposure defined as exposure in childhood for ≥10 years, in adult home for ≥20 years, and in adult work for ≥10 years.
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women reported that recent smoking had a borderline
association with risk of ductal cancer (odds ratio 1.2
(95% confidence interval 1.0 to 1.4)) but not with
other histological types.
50 Our findings suggesting a
particular association with lobular cancer should be
considered preliminary. A few studies examining
smoking in relation to subtypes of breast cancer by
hormone receptor status have yielded mixed
results.
51-54 Some have reported an association with
hormone receptor positive cancer,
5354 but others have
reported the opposite
5152 or no association.
55 Finally,
Kabat et al studied active smoking and ductal carci-
nomainsitu(487casesamong63393womenenrolled
in the Women’s Health Initiative) and did not find an
association.
56 More large studies are needed to clarify
these relations.
Strengths and limitations of the study
Our study’s strengths include the prospective design,
the large size and broad geographical distribution of
the cohort, the large number of cancer cases, patholo-
gicalconfirmationofcasesbytrainedadjudicatorsand
cancer coders, detailed information on potential con-
founders, and, particularly, detailed information on
passive smoking, including quantitative measures of
exposure in childhood and adult exposure in residen-
tial and workplace settings.
However, our study also has limitations. One is that
we used only baseline values for women’s smoking
status and all covariates and did not account for
changes in exposure during follow-up, which may
have caused some exposure misclassification and
biased our results towards the null. However, given
thatourstudypopulationconsistedofpostmenopausal
womenandthatfewwerecurrentsmokers,theeffectof
changes in smoking status during follow-up is likely to
have been minimal. Based on yearly reassessment of
smoking status in the Women’s Health Initiative,
about 60% of smokers continued to smoke for six
years of follow-up and 99% of non-smokers remained
abstinent.
Secondly, there was possible recall bias with regard
topassivesmokingexposureinchildhood.Inaddition,
datawerenotcollectedfortheintensityorfrequencyof
passive smoke exposure. The crude measures and
potential misclassification of exposure may make our
estimate more conservative. The lack of intensity or
frequency data also may have hampered our ability
to detect a dose-response relation.
Conclusions and policy implications
Ourstudysupportsthe hypothesisthatactivesmoking
is associated with an increased risk of breast cancer
among postmenopausal women. In addition, our data
suggest that extensive exposure to passive smoking
may increase breast cancer risk. However, since risk
of breast cancer was restricted to the most extensive
passivesmokingcategorywith noclear doseresponse,
theassociationwithpassivesmokingshouldbeconsid-
ered suggestive only and needs confirmation from
otherstudies.Ourfindingshighlighttheneedforinter-
ventions to prevent initiation of smoking, especially at
anearlyage,andtoencouragesmokingcessationatall
ages. Future studies examining how genetic poly-
morphisms and other risk factors modify the effect of
tobacco exposure on breast cancer risk are likely to
further our understanding of this important issue.
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